Pro-Dex (PDEX) Projected to Post Earnings on Thursday

Pro-Dex (NASDAQ:PDEX) is projected to announce its earnings results before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $0.38 per share and revenue of $13.80 million for the quarter.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings data on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, analysts expect Pro-Dex to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Pro-Dex Trading Down 5.4 %

Shares of Pro-Dex stock opened at $32.47 on Thursday. The stock has a market capitalization of $105.85 million, a P/E ratio of 16.15 and a beta of 0.53. Pro-Dex has a 12-month low of $16.18 and a 12-month high of $59.60. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.33. The company has a 50-day simple moving average of $46.84 and a 200 day simple moving average of $34.96.

Wall Street Analysts Forecast Growth

PDEX has been the topic of a number of research reports. StockNews.com cut shares of Pro-Dex from a “strong-buy” rating to a “buy” rating in a research note on Monday. Ascendiant Capital Markets increased their price objective on Pro-Dex from $30.00 to $52.00 and gave the company a “buy” rating in a research report on Monday, November 11th.

Insider Activity at Pro-Dex

In other news, Director Raymond E. Cabillot sold 6,931 shares of the business’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $45.22, for a total value of $313,419.82. Following the sale, the director now directly owns 337,752 shares in the company, valued at $15,273,145.44. The trade was a 2.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders sold a total of 27,770 shares of company stock worth $1,239,312 in the last quarter. Corporate insiders own 47.50% of the company’s stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.